Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 7 June 2023 HCWS831 on Public Health Update, whether he has made an estimate of the number of patients who will be eligible for Semaglutide in each year of the pilot.

The precise number of patients to be included in each year of the pilot will be finalised in due course, along with the service models being tested. In addition to Semaglutide (Wegovy), the pilots are expected to include Tirzepatide, subject to this receiving a license and approval from the National Institute for Health and Care Excellence and launching in the United Kingdom.